Have a personal or library account? Click to login
Effects of Roflumilast, Selective PDE4 Inhibitor, on Airway Reactivity in Ovalbumin-Sensitized Guinea Pigs Cover

Effects of Roflumilast, Selective PDE4 Inhibitor, on Airway Reactivity in Ovalbumin-Sensitized Guinea Pigs

Acta Medica Martiniana
Volume 15 (2015): Issue 1 (May 2015)
By: Nirmathan Tharmalingam,  I. Medvedova,  A. Eichlerova,  M. Prso,  D. Mokra and  J. Mokry  
Open Access
|Jun 2015

References

  1. 1. World Population Prospects. The 2006 Revision. Highlights. New York, United Nations, 2007.
    Search in Google Scholar
  2. 2. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee Report. Allergy 2004; 59:469-478.10.1111/j.1398-9995.2004.00526.x15080825
    Search in Google Scholar
  3. 3. British guideline on the management of asthma: a national clinical guide. British Thoracic Society 2012; 1-151.
    Search in Google Scholar
  4. 4. Barnes PJ. PAF, eosinophils and asthma. J Lipid Mediat 1992; 5(2): 155-158.
    Search in Google Scholar
  5. 5. Boulet LP, Turcotte H, Brochu A. Persistence of airway obstruction and hyperresponsiveness in subjects with asthma remission. Chest 1994; 105: 1024-1031.10.1378/chest.105.4.10248162720
    Search in Google Scholar
  6. 6. Sont JK, Han J, van Krieken JM, Evertse CE, Hooijer R, Willems LN, Sterk PJ.. The relationship between the inflammatory infiltrate in bronchial biopsies and clinical severity of asthma in patients treated with inhaled steroids. Thorax 1996; 51: 496-50210.1136/thx.51.5.4964735948711677
    Search in Google Scholar
  7. 7. Fatemi SH, King DP, Reutiman TJ, Folsom TD, Laurence JA, Lee S, Fan YT, Paciga SA, Conti M, Menniti FS. PDE4B polymorphisms and decreased PDE4B expression are associated with schizophrenia. Schizophrenia Res 2008; 101(1-3): 36-49.10.1016/j.schres.2008.01.02918394866
    Search in Google Scholar
  8. 8. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilator function adults with asthma. N Engl J Med 1998; 339: 1194-1200.10.1056/NEJM1998102233917039780339
    Search in Google Scholar
  9. 9. Grandoch M, Roscioni SS, Schmidt M. The role of Epac proteins, novel cAMP mediators, in the regulation of immune, lung and neuronal function. Br J Pharamacol 2010; 159: 265-284.10.1111/j.1476-5381.2009.00458.x282535019912228
    Search in Google Scholar
  10. 10. Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.10.1183/09031936.04.0001430415219010
    Search in Google Scholar
  11. 11. Fauci AS, Braunwald E, Kasper DL. Harrison s Principles of Internal Medicine. 17 etd. Mc Graw Hill 2008; 254: 1635-1643.
    Search in Google Scholar
  12. 12. Giembycz MA, Field SK. Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD. Drug Des Devel Ther 2010; 4: 147-158.
    Search in Google Scholar
  13. 13. Bethke TD, Lahu G.. High absolute bioavailability of the new oral phosphodiesterase-4 inhibitor roflumilast. Int J Clin Pharmacol Ther 2011; 49(1): 51-57.10.5414/CPP4905121176727
    Search in Google Scholar
  14. 14. Daxas R. Product information. Nycomed AG, Dubendorf, Switzerland 2012.
    Search in Google Scholar
  15. 15. Karish SB, Gagnon JM. The potential role of roflumilast: the new phosphodiesterase-4 inhibitor. Ann Pharmacother 2006; 40: 1096-1104.10.1345/aph.1E65116735669
    Search in Google Scholar
  16. 16. Fabbri LM, Beghe B, Yasothan U, Kirkpatrick P. Roflumilast. Nature Reviews Drug Discovery 2010; 9: 761-762.10.1038/nrd327620885403
    Search in Google Scholar
  17. 17. Gross NJ, Giembycz MA, Rennard SI. Treatment of chronic obstructive pulmonary disease with roflumilast, a new phosphodiesterase 4 inhibitor. COPD 2010; 7(2): 141-53.10.3109/15412551003758304
    Search in Google Scholar
  18. 18. Mokry J, Mokra D, Nosalova G, Beharkova M, Feherova Z. Influence of selective inhibitors of phosphodiesterase 3 and 4 on cough and airway reactivity. J Physiol Pharmacol 2008; 59: 473-82.
    Search in Google Scholar
  19. 19. Lipworth BJ. Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease. Lancet 2005; 365: 167-175.10.1016/S0140-6736(05)17708-3
    Search in Google Scholar
  20. 20. Mokry J, Mokra D. Immunological aspects of phosphodiesterase inhibition in the respiratory system. Respir Physiol Neurobiol 2013; 187(1): 11-17.10.1016/j.resp.2013.02.004
    Search in Google Scholar
  21. 21. Mokry J, Joškova M, Mokra D, Christensen I, Nosaľova G. Effects of selective inhibition of PDE4 and PDE7 on airway reactivity and cough in healthy and ovalbumin-sensitized guinea pigs. Adv Exp Med Biol 2013; 756: 57-63.10.1007/978-94-007-4549-0_8
    Search in Google Scholar
  22. 22. Mokry J, Nosalova G, Mokra D. Influence of xanthine derivatives on cough and airway reactivity in guinea pigs. J Physiol Pharmacol 2009; 60: 87-91.
    Search in Google Scholar
  23. 23. Mokry J, Nosalova G. The influence of the PDE inhibitors on cough reflex in guinea pigs. Bratisl Lek Listy 2011; 112(3): 131-5.
    Search in Google Scholar
  24. 24. Mokry J, Mokra D. Phosphodiesterases and their inhibitors in some respiratory system disorders. In: Neonatal Care: New Research. New York: Nova Science Publishers 2013: 29-53.
    Search in Google Scholar
  25. 25. Fabbri LM, Calverley PM, Izquierdo-Alonso JL, et al. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. Lancet 2009; 374(9691): 695-703.10.1016/S0140-6736(09)61252-6
    Search in Google Scholar
  26. 26. Calverley PM, Rabe KF, Goehring UM, et al. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet 2009; 374(9691): 685-94. Erratum in: Lancet 2010; 376(9747): 1146.
    Search in Google Scholar
  27. 27. Calzetta L, Page CP, Spina D, et al. Effect of the mixed phosphodiesterase 3/4 inhibitor RPL554 on human isolated bronchial smooth muscle tone. J Pharmacol Exp Ther 2013; 346(3): 414-423.10.1124/jpet.113.20464423766543
    Search in Google Scholar
  28. 28. Christensen I, Miskovicova H, Porvaznik I, Joskova M, Mokra D, Mokry J. Selective Inhibition of Phosphodiesterase 7 (PDE7) by BRL50481 in Healthy and Ovalbumin-Sensitized Guinea Pigs. Acta Med Mart 2012; 12 (Supple 1): 16-23.10.2478/v10201-011-0023-7
    Search in Google Scholar
  29. 29. Medvedova I, Prso M, Eichlerova A, Mokra D, Mikolka P, Mokry J. Influence of roflumilast on airway reactivity and apoptosis in ovalbumin-sensitized Guinea pigs. Adv Exp Med Biol 2015; 838: 11-18.10.1007/5584_2014_7725310957
    Search in Google Scholar
DOI: https://doi.org/10.1515/acm-2015-0002 | Journal eISSN: 1338-4139 | Journal ISSN: 1335-8421
Journal RSS Feed
Language: English
Page range: 12 - 19
Submitted on: Mar 18, 2015
|
Accepted on: Apr 10, 2015
|
Published on: Jun 16, 2015
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year
Keywords:
roflumilast,
ovalbumin,
phosphodiesterase inhibitors,
airway reactivity,
eosinophil inflammation,
bronchial asthma
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Cardiology

© 2015 Nirmathan Tharmalingam, I. Medvedova, A. Eichlerova, M. Prso, D. Mokra, J. Mokry, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 15 (2015): Issue 1 (May 2015)Next article